#How to Invest in Medicus Pharma (NASDAQ: MDCX) – A Step-by-Step Guide
🚀 Why Invest in Medicus Pharma (MDCX)?
Medicus Pharma Ltd. (NASDAQ: MDCX) is advancing a cutting-edge approach to treating the world’s most common skin cancer1 - basal cell carcinoma (BCC). Through its subsidiary SkinJect, the company is developing a first-in-class, non-invasive microneedle patch designed to revolutionize BCC treatment. With a $7B+ market opportunity2 and secured patents through 2035, Medicus Pharma’s lead asset is progressing through a Phase 2 clinical trial, targeting a streamlined regulatory pathway to commercialization3.
Breakthrough treatment option for the 5 million+ basal cell carcinoma cases diagnosed annually in the U.S.2
$7B+ market opportunity2
Analyst price targets of $10 (Maxim Group) and $12 (Brookline Capital)4 (over 240% to 300% upside based on $2.90 closing price on March 5, 2025)4
(Note: Analyst targets are based on projections and assumptions that may not materialize.)Strong IP protection with patents through to 20352
Backed by university-developed technology5,6
Phase 2 trial progress with a clear regulatory path3
#🛠 Step-by-Step: How to Buy MDCX Stock
Step 1: Choose a Brokerage Account
If you already have an account with a brokerage, skip to Step 2. If not, you’ll need to open one to purchase MDCX stock.
Popular brokerage platforms include:
United States:
Canada:
Some platforms charge fees, while others offer commission-free trading. Some brokerages also allow fractional share purchases.
Step 2: Fund Your Account
Once your brokerage account is set up, you need to deposit funds. Most brokerages allow funding via:
Bank transfer (ACH, wire transfer)
Debit/credit card (if applicable)
Transfers from another brokerage
Step 3: Search for MDCX on Your Brokerage Platform
Use the stock ticker: MDCX to locate Medicus Pharma stock on your chosen brokerage platform.
Step 4: Decide How Much to Invest
Determine how much you want to invest based on your financial goals and risk tolerance. Many investors use dollar-cost averaging (DCA) to reduce market timing risk.
Step 5: Place Your Order
There are different order types available:
Market Order: Buy MDCX at the current market price.
Limit Order: Set a specific price at which you want to purchase MDCX.
Stop-Loss Order: Protect against potential losses by setting a sell trigger.
Step 6: Review & Confirm Your Trade
Double-check your order details before submitting. Once confirmed, your broker will execute the trade, and you’ll officially own shares of Medicus Pharma.
#💡 Why Invest in MDCX Now?
Basal cell carcinoma (BCC) is the world’s most common skin cancer. Over 5 million new BCC cases are diagnosed annually in the U.S.2, yet the current standard of care, Mohs surgery, can only accommodate around 870K procedures per year.4 This leaves millions of patients underserved, often resorting to less effective treatments or facing long wait times.
Medicus Pharma is targeting a $2B+ share of this market2 with its first-in-class, non-invasive microneedle patch, designed to provide a more accessible, convenient, and patient-friendly alternative to surgery.
Breakthrough treatment option for the 5 million+ basal cell carcinoma cases diagnosed annually in the U.S.2
$7B+ market opportunity2
Analyst price targets of $10 (Maxim Group) and $12 (Brookline Capital)4 (over 240% to 300% upside based on $2.90 closing price on March 5, 2025)4
(Note: Analyst targets are based on projections and assumptions that may not materialize.)Strong IP protection with patents through to 20352
Backed by university-developed technology5,6
Phase 2 trial progress with a clear regulatory path3
Led by Big Pharma Veterans from Pfizer, Novartis, and GSK3
Strong Financial Position & Shareholder Alignment3
#📚 Additional Resources for Investors
✅ Latest Investor Presentation
✅ SEC Filings & Financial Reports